Market Cap 18.87M
Revenue (ttm) 2.07M
Net Income (ttm) -3.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -170.53%
Debt to Equity Ratio 0.00
Volume 14,600
Avg Vol 24,908
Day's Range N/A - N/A
Shares Out 4.68M
Stochastic %K 69%
Beta 1.76
Analysts Strong Buy
Price Target $8.00

Company Profile

Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. The company is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 327 8778
Address:
245 First Street, Riverview II, 18th Floor, Cambridge, United States
Harrisford222
Harrisford222 Aug. 19 at 7:30 AM
$CYCN pump&DUMB
0 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 18 at 8:10 PM
$CYCN This is an interesting table of all of the spin-off companies of Paragon Therapeutics that went public, their various drug areas/phases, and valuations. CYCN will be the bottom one (Korsana). Notice even the super early stage Phase 1 / Pre-clinical ones are still valued around ~1B + . Seems like Paragon companies are pretty successful. No wonder this one has over 500m in funding starting out. Highly sought after it seems.
1 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 18 at 6:43 PM
$CYCN CYCN CVR 10% ownership in Tisento analysis (deadline to buy CYCN shares likely Mon of next week): -Tisento Series A funding in 2023 was 88m, implying a roughly 160-200m valuation. 10% stake is through first 100m post money valuation so CYCN stake likely in 7-8% range, or roughly 14m or $3/share currently. -Tisento Phase 2b data readout upcoming and subsequent Series B funding round. If data is good likely will be valued 2-3x Series A, or 400-600m. CYCN CVR stake would be worth roughly 32-48m or 6.80 - 10.20/share. -If Tisento is eventually a takeover target or IPOs valuation could be 1B+ and CYCN stake is worth MASSIVE 80m or $17/share . Lots of potential upside for a free lotto ticket CVR. And I'm not even including the royalties and milestone payments that may come from the $AKBA praliciguat agreement.
0 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 18 at 3:21 PM
$CYCN so thin wait til volume comes ran from 1.50 to 8.50 when merger was announced on 4/1 the trend up is starting here, big move coming into the 8/26 shareholder vote https://x.com/thommic/status/2089734220746838325?s=20
0 · Reply
Wakaas93
Wakaas93 Aug. 18 at 2:21 PM
@stockbot1234 $HCWC merger vote 27th August $CYCN merger vote 26th August
1 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 18 at 1:55 PM
$CYCN and $HCWC both have shareholder special meetings to vote on approval of their respective mergers on 8/26 and 8/27, big catalysts should start moving into those dates
1 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 17 at 6:54 PM
$CYCN Just a friendly reminder to anyone that wants CYCN CVRs, you have to own the stock before the merger closing which is likely next Wed Aug 26.
1 · Reply
CEMBP_Trader
CEMBP_Trader Aug. 17 at 3:21 PM
$CYCN Ownership summary per Fidelity. This seems to account for over 100%. Not sure what’s that negative Institutional Ownership of 5.3% 🍀🎉🍀
0 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 17 at 3:14 PM
$CYCN Lots of new tute ownership flowing into this for the merger w/ Korsana. 75% owned by institutions now, from 15% before. No wonder it's impossible to buy shares.....
0 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 17 at 2:25 PM
$CYCN not much vol yet but bids coming in should start moving into the 8/26 merger vote for Korsana Biosciences Reverse Merger went to $8 on 4/1 when announced
0 · Reply
Latest News on CYCN
Cyclerion Therapeutics files $25M mixed securities shelf

2025-02-04T21:45:08.000Z - 1 year ago

Cyclerion Therapeutics files $25M mixed securities shelf


Biotech Alert: Searches spiking for these stocks today

2024-11-18T15:55:13.000Z - 1 year ago

Biotech Alert: Searches spiking for these stocks today

TFFP


Cyclerion Therapeutics appoints Regina Graul as CEO

2024-08-07T11:26:09.000Z - 2 years ago

Cyclerion Therapeutics appoints Regina Graul as CEO


Regina Graul, Ph.D., Promoted to Chief Executive Officer

Aug 7, 2024, 7:00 AM EDT - 2 years ago

Regina Graul, Ph.D., Promoted to Chief Executive Officer


Cyclerion Therapeutics appoints Graul as President

2023-12-04T13:04:15.000Z - 2 years ago

Cyclerion Therapeutics appoints Graul as President


Cyclerion Appoints Regina Graul, Ph.D., as President

Dec 4, 2023, 8:00 AM EST - 2 years ago

Cyclerion Appoints Regina Graul, Ph.D., as President


Cyclerion Announces Reverse Stock Split

May 15, 2023, 1:00 PM EDT - 3 years ago

Cyclerion Announces Reverse Stock Split


Cyclerion Therapeutics to Host Pipeline Update Webinar

Apr 20, 2021, 7:00 AM EDT - 5 years ago

Cyclerion Therapeutics to Host Pipeline Update Webinar


Harrisford222
Harrisford222 Aug. 19 at 7:30 AM
$CYCN pump&DUMB
0 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 18 at 8:10 PM
$CYCN This is an interesting table of all of the spin-off companies of Paragon Therapeutics that went public, their various drug areas/phases, and valuations. CYCN will be the bottom one (Korsana). Notice even the super early stage Phase 1 / Pre-clinical ones are still valued around ~1B + . Seems like Paragon companies are pretty successful. No wonder this one has over 500m in funding starting out. Highly sought after it seems.
1 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 18 at 6:43 PM
$CYCN CYCN CVR 10% ownership in Tisento analysis (deadline to buy CYCN shares likely Mon of next week): -Tisento Series A funding in 2023 was 88m, implying a roughly 160-200m valuation. 10% stake is through first 100m post money valuation so CYCN stake likely in 7-8% range, or roughly 14m or $3/share currently. -Tisento Phase 2b data readout upcoming and subsequent Series B funding round. If data is good likely will be valued 2-3x Series A, or 400-600m. CYCN CVR stake would be worth roughly 32-48m or 6.80 - 10.20/share. -If Tisento is eventually a takeover target or IPOs valuation could be 1B+ and CYCN stake is worth MASSIVE 80m or $17/share . Lots of potential upside for a free lotto ticket CVR. And I'm not even including the royalties and milestone payments that may come from the $AKBA praliciguat agreement.
0 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 18 at 3:21 PM
$CYCN so thin wait til volume comes ran from 1.50 to 8.50 when merger was announced on 4/1 the trend up is starting here, big move coming into the 8/26 shareholder vote https://x.com/thommic/status/2089734220746838325?s=20
0 · Reply
Wakaas93
Wakaas93 Aug. 18 at 2:21 PM
@stockbot1234 $HCWC merger vote 27th August $CYCN merger vote 26th August
1 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 18 at 1:55 PM
$CYCN and $HCWC both have shareholder special meetings to vote on approval of their respective mergers on 8/26 and 8/27, big catalysts should start moving into those dates
1 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 17 at 6:54 PM
$CYCN Just a friendly reminder to anyone that wants CYCN CVRs, you have to own the stock before the merger closing which is likely next Wed Aug 26.
1 · Reply
CEMBP_Trader
CEMBP_Trader Aug. 17 at 3:21 PM
$CYCN Ownership summary per Fidelity. This seems to account for over 100%. Not sure what’s that negative Institutional Ownership of 5.3% 🍀🎉🍀
0 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 17 at 3:14 PM
$CYCN Lots of new tute ownership flowing into this for the merger w/ Korsana. 75% owned by institutions now, from 15% before. No wonder it's impossible to buy shares.....
0 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 17 at 2:25 PM
$CYCN not much vol yet but bids coming in should start moving into the 8/26 merger vote for Korsana Biosciences Reverse Merger went to $8 on 4/1 when announced
0 · Reply
CEMBP_Trader
CEMBP_Trader Aug. 17 at 7:07 AM
$CYCN Institutional holdings updated to the 6/30/26 quarter 🍀🎉🍀
0 · Reply
Wakaas93
Wakaas93 Aug. 15 at 4:43 PM
$CYCN Adding for merger vote
0 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 13 at 6:29 PM
$CYCN new highs run coming into 8/26 merger vote, chart looking fantastic!
0 · Reply
skyrockets_Inc
skyrockets_Inc Aug. 13 at 3:59 PM
$CYCN Any of my original Cyclerion pals still here? I've added back in over the past few weeks in anticipation for Korsana RM and CVRs. 10% stake in Tisento on CVR could be worth more than current market cap by itself.
2 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 13 at 2:10 PM
$CYCN low vol for now but gonna move into the 8/26 merger vote for Korsana Biosciences Reverse Merger , moved to over 8 apr 1 on announcement think itll walk up
0 · Reply
Golden_Cross
Golden_Cross Aug. 12 at 4:58 PM
$CYCN Worth adding here..........
0 · Reply
i_like_bb_stock
i_like_bb_stock Aug. 12 at 4:46 PM
$CYCN took starter special meeting on 8/26 for approval of merger with Korsana Biosciences and name /ticker change, should walk up into the date it doubled on 4/1 when announced
0 · Reply
JZen_
JZen_ Aug. 11 at 1:05 AM
$CYCN Been doing some digging on this one and I think it's pretty interesting. They have a pending merger with Korsana that's still expected to close sometime in Q3, along with a ~$380M private financing expected to close right before the merger. But what really caught my attention is how small CYCN is. Only around 4.3M shares outstanding w/ roughly 2.5-2.8M float, and it's still holding around the mid-3s Not calling this an alert right now, just sharing some of the research I've been doing. $3.75/$4 is what I'd want to see it start clearing, but I don't look at that as the upside if the actual merger catalyst hits. With a float this small, if the closing news brings real volume, I think this could go a lot higher. We already saw what happened when the original merger news dropped back in April and it traded above $8. Just worth keeping on your radar while we get deeper into Q3
0 · Reply
ajmrtxl
ajmrtxl Aug. 7 at 6:31 PM
$CYCN 's latest squeeze play
1 · Reply
ShadowSnake
ShadowSnake Aug. 7 at 5:50 PM
$CYCN took the loss … f this stock… now watch it run over $10… 🤬🤬🤬🤬
0 · Reply
ShadowSnake
ShadowSnake Aug. 5 at 10:33 PM
$CYCN yeah everyone be sure to vote to increase shares from 400M to 700M and approve a reverse split… 🤬🤬
0 · Reply
LHProxy
LHProxy Aug. 5 at 9:33 PM
$CYCN *Upcoming Annual Meeting - Please vote your shares today*
0 · Reply